Innovative approaches in drug discovery: webinar to highlight AI-driven 3D/4D image analysis

Innovative Approaches in Drug Discovery: Webinar to Highlight AI-Driven 3D/4D Image Analysis

The landscape of drug development is experiencing a transformation with the integration of advanced in vitro models and cutting-edge imaging technologies. This shift has been propelled by the recent approval from the US Food and Drug Administration (FDA) of organoids in preclinical research. As researchers strive to make drug testing and disease research more biologically relevant, complex in vitro models (CIVM) are taking centre stage.

On the cusp of these advancements, a significant webinar is set to take place, hosted by Drug Development World (DDW) with support from Zeiss, a leading optics and optoelectronics company. This event aims to delve into the challenges and innovations surrounding CIVM, focusing particularly on imaging and analysis techniques that have emerged in response to the evolving needs of the field.

Traditional 2D high-content analysis (HCA) methods are increasingly proving insufficient for the intricate task of capturing detailed 3D biological information. Many existing 3D cell culturing techniques produce results with high variability, complicating consistent analysis and testing outcomes. To address this, modern microscopy systems now generate detailed 3D/4D datasets that allow for unparalleled insights into cellular structures, thus facilitating a more nuanced understanding of biological processes.

Participants in the webinar will gain insights into a variety of topics related to these advanced models. Key discussions will include the automation of CIVM generation and the scalability of quantification processes. The event will explore both brightfield and fluorescent imaging techniques specifically designed for capturing complex 3D cell cultures. Moreover, the application of artificial intelligence and parallel computing will be discussed as pivotal tools in performing robust analysis of 3D hydrogel cultures.

The webinar will also address how modern imaging technologies can enhance the detection of drug response patterns across expansive 3D datasets. This is particularly significant for streamlining drug discovery, as it allows for quicker and more efficient identification of potential therapies.

Following the presentations, a question-and-answer session will provide attendees with the opportunity to engage directly with the speakers. This interactive component is designed to enrich the learning experience by addressing specific queries and discussing real-world applications of these sophisticated technologies.

This event underscores the vital role of technology in enhancing the precision and efficacy of drug discovery processes. By integrating AI-powered 3D/4D image analysis into their research, scientists can unlock new potentials in understanding diseases and developing treatments, marking a new era in pharmaceutical innovation.

Source: Noah Wire Services